Lensar (LNSR) Change in Account Payables (2019 - 2026)
Lensar (LNSR) reported Change in Account Payables of -$3.9 million for Q1 2026, down 320.98% year-over-year from $1.8 million in Q1 2025, and down 192.81% on a QoQ basis from $4.2 million in Q4 2025.
Lensar (LNSR) has 8 years of Change in Account Payables data on file, last reported at -$3.9 million in Q1 2026.
- Quarterly Change in Account Payables fell 320.98% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (up 97.92% YoY) and the FY2025 annual result came in at $13.0 million, up 563.96% from the prior year.
- Change in Account Payables slipped to -$3.9 million in Q1 2026 per LNSR's latest filing, from $4.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.2 million in Q4 2025 and bottomed at -$3.9 million in Q1 2026.
- The 5-year median for Change in Account Payables is $97000.0 (2024), against an average of $727529.4.
- The widest annual swing landed in 2023, when Change in Account Payables sank 415.82%; it then jumped 29216.67% in 2025.
- Tracing LNSR's Change in Account Payables over 5 years: stood at $1.9 million in 2022, then plunged by 96.3% to $72000.0 in 2023, then surged by 2809.72% to $2.1 million in 2024, then soared by 99.9% to $4.2 million in 2025, then sank by 192.81% to -$3.9 million in 2026.
- Per Business Quant, the three latest LNSR Change in Account Payables figures stand at -$3.9 million (Q1 2026), $4.2 million (Q4 2025), and $3.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.89 Mn |
| Mar 31, 2026 | -3.89 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | -242,000.00 |
| Sep 30, 2024 | -242,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Sep 30, 2023 | -685,000.00 |
| Sep 30, 2023 | -685,000.00 |
| Jun 30, 2023 | -305,000.00 |
| Jun 30, 2023 | -305,000.00 |
| Mar 31, 2023 | -499,000.00 |
| Mar 31, 2023 | -499,000.00 |
| Dec 31, 2022 | 1.95 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | -714,000.00 |
| Sep 30, 2022 | -714,000.00 |
| Jun 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 158,000.00 |
| Mar 31, 2022 | 158,000.00 |
| Dec 31, 2021 | 316,000.00 |
| Dec 31, 2021 | 316,000.00 |
| Sep 30, 2021 | -429,000.00 |
| Sep 30, 2021 | -429,000.00 |
| Jun 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 1.10 Mn |
| Mar 31, 2021 | -778,000.00 |
| Mar 31, 2021 | -778,000.00 |
| Dec 31, 2020 | 138,000.00 |
| Dec 31, 2020 | 138,000.00 |
| Sep 30, 2020 | 840,000.00 |
| Sep 30, 2020 | 840,000.00 |
| Jun 30, 2020 | -748,000.00 |
| Jun 30, 2020 | -748,000.00 |
| Mar 31, 2020 | 680,000.00 |
| Mar 31, 2020 | 680,000.00 |
| Dec 31, 2019 | -4.80 Mn |
| Dec 31, 2019 | -4.80 Mn |